Prognostic Value of Serum Neurofilament Light Chain for Disease Activity and Worsening in Patients With Relapsing Multiple Sclerosis: Results From the Phase 3 ASCLEPIOS I and II Trials

Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study

(2022) Pascal Benkert et al.   LANCET NEUROLOGY

The potential of serum neurofilament as biomarker for multiple sclerosis

(2021) Stefan Bittner et al.   BRAIN

Measurement of neurofilaments improves stratification of future disease activity in early multiple sclerosis

(2021) Tomas Uher et al.   Multiple Sclerosis Journal

Personalized medicine for multiple sclerosis: How to integrate neurofilament light chain levels in the decision?

(2021) Pablo Villoslada   Multiple Sclerosis Journal

Ofatumumab versus Teriflunomide in Multiple Sclerosis

(2020) Stephen L. Hauser et al.   NEW ENGLAND JOURNAL OF MEDICINE

Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis

(2020) Simon Thebault et al.   Scientific Reports

Thalamic Atrophy Predicts 5-Year Disability Progression in Multiple Sclerosis

(2020) Katariina Hänninen et al.   Frontiers in Neurology

Clinical implications of serum neurofilament in newly diagnosed MS patients: A longitudinal multicentre cohort study

(2020) Stefan Bittner et al.   EBioMedicine

Long-term prognostic value of longitudinal measurements of blood neurofilament levels

(2020) Dieter A. Häring et al.   Neurology-Neuroimmunology & Neuroinflammation

Blood neurofilament light chain as a biomarker of MS disease activity and treatment response

(2019) Jens Kuhle et al.   NEUROLOGY

Silent Progression in Disease Activity-Free Relapsing Multiple Sclerosis

(2019) et al.   ANNALS OF NEUROLOGY

Neurofilament light chain in the assessment of patients with multiple sclerosis

(2019) Renan Barros DOMINGUES et al.   ARQUIVOS DE NEURO-PSIQUIATRIA

Serum neurofilament light chain levels associations with gray matter pathology: a 5‐year longitudinal study

(2019) Dejan Jakimovski et al.   Annals of Clinical and Translational Neurology

An argument for broad use of high efficacy treatments in early multiple sclerosis

(2019) James M. Stankiewicz et al.   Neurology-Neuroimmunology & Neuroinflammation

Serum neurofilament as a predictor of disease worsening and brain and spinal cord atrophy in multiple sclerosis

(2018) Christian Barro et al.   BRAIN

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Fingolimod effect on gray matter, thalamus, and white matter in patients with multiple sclerosis

(2018) Laura Gaetano et al.   NEUROLOGY

Practice guideline recommendations summary: Disease-modifying therapies for adults with multiple sclerosis

(2018) Alexander Rae-Grant et al.   NEUROLOGY

Serum neurofilament light chain is a biomarker of acute and chronic neuronal damage in early multiple sclerosis

(2018) Nelly Siller et al.   Multiple Sclerosis Journal

ECTRIMS/EAN Guideline on the pharmacological treatment of people with multiple sclerosis

(2018) Xavier Montalban et al.   Multiple Sclerosis Journal

Prognostic value of cerebrospinal fluid neurofilament light chain and chitinase-3-like-1 in newly diagnosed patients with multiple sclerosis

(2018) Finn Sellebjerg et al.   Multiple Sclerosis Journal

Multiple sclerosis

(2018) Jiwon Oh et al.   CURRENT OPINION IN NEUROLOGY

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Serum neurofilament is associated with progression of brain atrophy and disability in early MS

(2017) Jens Kuhle et al.   NEUROLOGY

Plasma neurofilament light chain levels in patients with MS switching from injectable therapies to fingolimod

(2017) Fredrik Piehl et al.   Multiple Sclerosis Journal

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS

(2016) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Neurofilament Light Chain in Blood and CSF as Marker of Disease Progression in Mouse Models and in Neurodegenerative Diseases

(2016) Mehtap Bacioglu et al.   NEURON

Defining brain volume cutoffs to identify clinically relevant atrophy in RRMS

(2016) Maria Pia Sormani et al.   Multiple Sclerosis Journal

Serum neurofilament light chain in early relapsing remitting MS is increased and correlates with CSF levels and with MRI measures of disease severity

(2016) Jens Kuhle et al.   Multiple Sclerosis Journal

Neurofilament levels as biomarkers in asymptomatic and symptomatic familial amyotrophic lateral sclerosis

(2015) Patrick Weydt et al.   ANNALS OF NEUROLOGY

Serum neurofilament light chain levels are increased in patients with a clinically isolated syndrome

(2015) Giulio Disanto et al.   JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY

Correlation between brain volume loss and clinical and MRI outcomes in multiple sclerosis

(2015) E.-W. Radue et al.   NEUROLOGY

Neurofilament light chain: A prognostic biomarker in amyotrophic lateral sclerosis

(2015) C.-H. Lu et al.   NEUROLOGY

Association Between Thoracic Spinal Cord Gray Matter Atrophy and Disability in Multiple Sclerosis

(2015) Regina Schlaeger et al.   JAMA Neurology

Plasticity of the motor system in multiple sclerosis

(2014) D. Zeller et al.   NEUROSCIENCE

The thalamus and multiple sclerosis: Modern views on pathologic, imaging, and clinical aspects

(2013) A. Minagar et al.   NEUROLOGY

Increased Neurofilament Light Chain Blood Levels in Neurodegenerative Neurological Diseases

(2013) Johanna Gaiottino et al.   PLoS One

Association between pathological and MRI findings in multiple sclerosis

(2012) Massimo Filippi et al.   LANCET NEUROLOGY

Neurofilaments as biomarkers in multiple sclerosis

(2012) Charlotte E Teunissen et al.   Multiple Sclerosis Journal

Multiple sclerosis – candidate mechanisms underlying CNS atrophy

(2010) Volker Siffrin et al.   TRENDS IN NEUROSCIENCES

Multiple Sclerosis: An Immune or Neurodegenerative Disorder?

(2008) Bruce D. Trapp et al.   Annual Review of Neuroscience